
Rozalyn Rodwin
Director, Pediatric HEROS Survivorship Program; Small Group Leader, Scientific Inquiry Course · Yale-New Haven Hospital
Credentials: · · · · ·
History
2024–Present
Present
Present

2014–2015
- 2010–2014
- 2006–2010
Research
Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions
Review · Frontiers in Pain Research · 2022 · First of 4 authors · 28 citations
Adverse drug effects and angioedema hospitalizations in the United States from 2000 to 2009
Allergy and Asthma Proceedings · 2013 · 25 citations
Journal of the National Cancer Institute · 2022 · First of 15 authors · 21 citations
- NK
14 papers
- LB
6 papers
- AA
4 papers
- CA
4 papers

4 papers

4 papers

4 papers

4 papers
Grants
- 2026–2031
- 2024–2029
National Cancer Institute · K08
Contact PI · $766.7K · Yale University
Clinical trials
- 2025–2027
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
Principal investigator · Recruiting
Yale University
- 2024–2027
Site PI · Recruiting · Phase 2
Children's Oncology Group
- 2023–2029
Site PI · Recruiting
Children's Oncology Group
- 2023–2028
Site PI · Recruiting
Children's Oncology Group



